30 August 2024
From the 3rd to the 7th of September Immagina is attending Cold Spring Harbor Translational Control in New York! Join us there, and have a look at our poster depicting all our translatome solutions
22 January 2024
IMMAGINA announces today the release of a complete sample to data solution for ribosome profiling.
17 January 2024
Join us from January 23-25 at the mRNA-Based Therapeutics Summit Europe 2024 - in Berlin - for an introduction by our founder, unraveling the immense potential of leveraging a commercially validated "ribosome platform".
9 November 2023
"This is the first method that can quantify the abundance of tRNAs, and it can also look at tRNA modifications” Editorial Team, Nature Biotechnology
25 October 2022
A noncanonical function of EIF4E limits ALDH1B1 activity and increases susceptibility to ferroptosis. Nature Communications (2022)
30 August 2022
IMMAGINA Biotechnology, the Ribosome company, released today the AHARIBO Translatome RNAseq system, the first commercially available complete system to analyse gene expression at the ribosome level (Translatome).
